Palantir stock jumps after powerful Q2 2026 AI growth and higher guidance

Palantir Technologies Inc. (ISIN US69608A1088) stock is trading near $171 on Nasdaq as of August 13, 2026, after the data analytics and AI specialist delivered Q2 2026 revenue growth of 92.8% year over year and raised its full-year 2026 revenue guidance above $8.15 billion, underscoring how demand for its AI platforms is reshaping the company’s growth profile.

Q2 2026 earnings show explosive AI-driven growth

According to a detailed earnings recap from 24/7 Wall St., Palantir reported Q2 2026 revenue of $1.935 billion, up 92.8% compared with the same quarter a year earlier, reflecting how fast its AI-driven platforms are gaining traction with both commercial and government customers.

In the same quarter, adjusted earnings per share reached $0.41, beating the $0.28 analyst consensus cited in that report by $0.13 and marking Palantir’s ninth consecutive quarter of EPS outperformance, a pattern that reinforces management’s message that the business is scaling efficiently while expanding rapidly.

The earnings analysis also highlights that U.S. commercial revenue soared 149% year over year in Q2 2026, while overall company revenue grew 93% year over year and Palantir’s Rule of 40 score climbed to 155%, a level far above the 40% threshold that many SaaS investors use to gauge a healthy balance of growth and profitability.

Guidance raised and analyst consensus remains divided

Management’s confidence in the trajectory of the business is visible in its updated outlook. A same-day note on Yahoo Finance reports that Palantir raised its full-year 2026 revenue guidance to a range of $8.15 billion to $8.16 billion and reiterated expectations for GAAP profitability in every quarter, signaling that the company expects its AI platforms to sustain strong operating leverage as revenue scales.

That new guidance implies roughly 82% year-over-year revenue growth for 2026 compared with the prior year, as noted in the 24/7 Wall St. recap, a pace that stands out even within the broader high-growth AI software universe and helps explain why the stock now carries a premium valuation relative to many established software peers.

Despite the strong fundamentals, the analyst community remains divided. Data compiled by MarketBeat show a “Moderate Buy” consensus with an average price target of $192.19, above the current share price, but also note that two analysts rate the stock Strong Buy while three rate it Sell, reflecting sharply different views on how sustainable the current growth and valuation may be.

Meanwhile, a recent commentary summarized by MarketBeat points out that Jefferies has maintained an Underperform rating even after lifting its price target to $80 from $70, and that RBC Capital Markets also keeps an Underperform rating with a $90 price target, emphasizing concerns about slowing international revenue even as U.S. commercial and government segments beat expectations.

For investors, this mix of rapid growth, raised guidance, and cautious voices from major Wall Street firms creates a tension: the numbers point to exceptional momentum, but some analysts argue that Palantir’s valuation already embeds a great deal of future success.

AI platforms, U.S. demand and cash generation

A separate analysis from Trefis highlights how Palantir’s premium valuation is anchored in surging demand from one country in particular: the United States. In Q2 2026, U.S. commercial revenue grew 149% year over year, while U.S. government revenue increased 90%, and U.S. customers now account for more than 81% of total revenue.

The same Trefis report notes that Palantir’s revenue has grown at an average annual rate of 46.3% over the last three years, compared with roughly 5.9% for the S&P 500 constituents over the same period, showing how the company’s top line is expanding nearly eight times faster than the broad U.S. equity benchmark.

Operational metrics are equally striking. Trefis cites an operating margin of 42.8% and indicates that 55.2% of revenue converts into operating cash flow in the most recent quarter, meaning more than half of every dollar of sales becomes cash that can be reinvested into growth, product development, and new hiring without relying heavily on external financing.

The article also mentions that total remaining deal value grew 83% year over year to $13.1 billion in Q2 2026, signaling that Palantir’s pipeline of signed contracts continues to expand and that the company has substantial visibility into future revenue from both commercial enterprises and government agencies.

For investors comparing AI software names, these figures suggest Palantir is not only growing rapidly but also doing so with a strong margin and cash generation profile, a combination that partly explains why the stock’s valuation multiple remains above many traditional software peers despite recent volatility.

Current share price, volatility and U.S. market anchor

On the market side, a real-time quote snapshot from MEXC shows Palantir trading at $171.09 as of August 13, 2026, with the page indicating that this reflects a move of -2.20% or $-3.85 versus a previous closing price, underlining the stock’s tendency to swing sharply even on days without major corporate announcements.

Other coverage over the past day points out that Palantir shares recently traded near $175.52 at a market capitalization of around $420 billion, according to a valuation summary referenced from Yahoo Finance in a separate analysis, illustrating how quickly the company’s equity value has expanded as investors have priced in its AI growth story.

MarketBeat’s institutional flow note mentions that one ETF holder, Tema ETFs LLC, has a $5.54 million stake in Palantir and reiterates that analysts’ average price target of $192.19 stands above the current quote, suggesting that, on balance, Wall Street still expects upside from current levels even as a minority of analysts warn about downside risks.

Because Palantir trades on Nasdaq in the United States and is often analyzed alongside other large-cap U.S. technology and AI names that populate the Nasdaq-100 and S&P 500, its share price tends to respond not only to company-specific news but also to broader moves in U.S. growth and AI segments, particularly on days when macro data or interest-rate expectations shift.

Palantir Foundry and its role in AI adoption

One of Palantir’s flagship products is the Foundry platform, which is designed to help commercial organizations integrate vast amounts of operational data, build modular workflows, and deploy AI models directly into decision-making processes ranging from supply-chain optimization to financial risk management.

Foundry typically sits on top of a customer’s existing data infrastructure, connects to multiple data sources, and then provides a unified interface where business users and data scientists can collaborate on building applications, monitoring performance, and tuning AI models, making it easier for non-technical teams to work with complex analytics.

In recent quarters, management has emphasized Foundry’s role as an operating system for the modern enterprise, pointing to examples where the platform has helped customers reduce waste, improve forecasting accuracy, or streamline regulatory reporting, all of which can translate into tangible financial benefits and deepen long-term customer relationships.

For investors, the traction of Foundry in U.S. commercial accounts is a critical piece of the growth thesis: as more large organizations embed the platform into their core operations, the likelihood of long-duration contracts and upsell opportunities increases, supporting the revenue and remaining deal value figures now visible in Palantir’s Q2 2026 metrics.

Shares trade near $171 with elevated expectations

As of August 13, 2026, 6:04 a.m. ET, the MEXC quote snapshot shows Palantir Technologies Inc. at $171.09 per share, reflecting a daily move of -2.20% from the prior closing level, in a market environment where the stock has gained roughly 34.5% over the past month but remains below its 52-week high according to recent analytical commentary.